Home » Topics » BioWorld Science

BioWorld Science
RSS

Na+/H+-exchange inhibitors from Sumitomo

June 14, 1996

Cardiovascular disorders treatment from Boryung Pharm.

June 14, 1996

Merck & Co. discloses endothelin antagonists

June 14, 1996

Endothelin antagonists from Abbott

June 14, 1996

PDE IV inhibitor selected for further study

June 14, 1996

Sankyo reveals PAF antagonists

June 14, 1996

LTB4 antagonists from Pfizer

June 14, 1996

Schering-Plough seeks Nasonex approval

June 14, 1996

Cypros conferred SBIR grant to develop CPC-111 prodrugs

June 14, 1996

Activase cleared by FDA for ischemic stroke

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...